Nextrials, Inc. Co-Founder James H. Rogers Named to PharmaVOICE 100

SAN RAMON, Calif.--(BUSINESS WIRE)--Nextrials, Inc., a leader in clinical research software and services, today announced that company co-founder, president and CEO James H. Rogers has been named to the PharmaVOICE 100 list in recognition of his long career of innovative contributions to the pharmaceutical and biotechnology industries. The PharmaVOICE 100 list annually showcases the greatest influencers impacting corporate leadership, research and development, technology, creativity, marketing and business strategies within the life sciences.
MORE ON THIS TOPIC